Management of advanced heart failure in the elderly: Ethics, economics, and resource allocation in the technological era

Keith M. Swetz, John M. Stulak, Shannon M Dunlay, Ellin F. Gafford

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Significant strides have been made in the durability, portability, and safety of mechanical circulatory support devices (MCS). Although transplant is considered the standard treatment for advanced heart failure, limits in organ availability leave a much larger pool of recipients in need versus donors. MCS is used as bridge to transplantation and as destination therapy (DT) for patients who will have MCS as their final invasive therapy with transplant not being an option. Despite improvements in quality of life (QOL) and survival, defining the optimal candidate for DT may raise questions regarding the economics of this approach as well as ethical concerns regarding just distribution of goods and services. This paper highlights some of the key ethical issues related to justice and the costs of life-prolonging therapies with respect to resource allocations. Available literature, current debates, and future directions are discussed herein.

Original languageEnglish (US)
Article number524961
JournalCardiology Research and Practice
Volume1
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Resource Allocation
Ethics
Heart Failure
Economics
Equipment and Supplies
Transplants
Therapeutics
Social Justice
Transplantation
Quality of Life
Tissue Donors
Safety
Costs and Cost Analysis
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Management of advanced heart failure in the elderly : Ethics, economics, and resource allocation in the technological era. / Swetz, Keith M.; Stulak, John M.; Dunlay, Shannon M; Gafford, Ellin F.

In: Cardiology Research and Practice, Vol. 1, No. 1, 524961, 2012.

Research output: Contribution to journalArticle

@article{36f8a26a68b74672984a4f22edf52a3c,
title = "Management of advanced heart failure in the elderly: Ethics, economics, and resource allocation in the technological era",
abstract = "Significant strides have been made in the durability, portability, and safety of mechanical circulatory support devices (MCS). Although transplant is considered the standard treatment for advanced heart failure, limits in organ availability leave a much larger pool of recipients in need versus donors. MCS is used as bridge to transplantation and as destination therapy (DT) for patients who will have MCS as their final invasive therapy with transplant not being an option. Despite improvements in quality of life (QOL) and survival, defining the optimal candidate for DT may raise questions regarding the economics of this approach as well as ethical concerns regarding just distribution of goods and services. This paper highlights some of the key ethical issues related to justice and the costs of life-prolonging therapies with respect to resource allocations. Available literature, current debates, and future directions are discussed herein.",
author = "Swetz, {Keith M.} and Stulak, {John M.} and Dunlay, {Shannon M} and Gafford, {Ellin F.}",
year = "2012",
doi = "10.1155/2012/524961",
language = "English (US)",
volume = "1",
journal = "Cardiology Research and Practice",
issn = "2090-8016",
publisher = "Hindawi Publishing Corporation",
number = "1",

}

TY - JOUR

T1 - Management of advanced heart failure in the elderly

T2 - Ethics, economics, and resource allocation in the technological era

AU - Swetz, Keith M.

AU - Stulak, John M.

AU - Dunlay, Shannon M

AU - Gafford, Ellin F.

PY - 2012

Y1 - 2012

N2 - Significant strides have been made in the durability, portability, and safety of mechanical circulatory support devices (MCS). Although transplant is considered the standard treatment for advanced heart failure, limits in organ availability leave a much larger pool of recipients in need versus donors. MCS is used as bridge to transplantation and as destination therapy (DT) for patients who will have MCS as their final invasive therapy with transplant not being an option. Despite improvements in quality of life (QOL) and survival, defining the optimal candidate for DT may raise questions regarding the economics of this approach as well as ethical concerns regarding just distribution of goods and services. This paper highlights some of the key ethical issues related to justice and the costs of life-prolonging therapies with respect to resource allocations. Available literature, current debates, and future directions are discussed herein.

AB - Significant strides have been made in the durability, portability, and safety of mechanical circulatory support devices (MCS). Although transplant is considered the standard treatment for advanced heart failure, limits in organ availability leave a much larger pool of recipients in need versus donors. MCS is used as bridge to transplantation and as destination therapy (DT) for patients who will have MCS as their final invasive therapy with transplant not being an option. Despite improvements in quality of life (QOL) and survival, defining the optimal candidate for DT may raise questions regarding the economics of this approach as well as ethical concerns regarding just distribution of goods and services. This paper highlights some of the key ethical issues related to justice and the costs of life-prolonging therapies with respect to resource allocations. Available literature, current debates, and future directions are discussed herein.

UR - http://www.scopus.com/inward/record.url?scp=84871437545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871437545&partnerID=8YFLogxK

U2 - 10.1155/2012/524961

DO - 10.1155/2012/524961

M3 - Article

C2 - 23259150

AN - SCOPUS:84871437545

VL - 1

JO - Cardiology Research and Practice

JF - Cardiology Research and Practice

SN - 2090-8016

IS - 1

M1 - 524961

ER -